Skip to main content
. Author manuscript; available in PMC: 2024 Oct 1.
Published in final edited form as: Nat Immunol. 2023 Aug 10;24(10):1748–1761. doi: 10.1038/s41590-023-01589-9

Fig. 7 |. Inflammatory and cytotoxic human exTreg genes overexpressed in individuals with coronary artery disease.

Fig. 7 |

a, Genes that were significantly upregulated in human exTreg cells compared to Treg cells (2,803 genes) in the human bulk RNA-seq data (Fig. 3) were intersected with the genes present in the published human scRNA-seq panel (Fig. 2). Donor details for human bulk RNA-seq are in Supplementary Table 13 and those for scRNA-seq are in ref. 21. b, Mean expression of genes in CD16+CD56+ exTreg cells from the scRNA-seq dataset that were significantly increased in CAD+ non-diabetic (brown circles in top, n = 7) or diabetic (red squares in bottom, n = 11) individuals in comparison to control CAD non-diabetic (black circles, n = 12) individuals. Results are shown as the mean ± s.e.m. Each point represents data from exTreg cells from an independent donor. Statistical comparisons were done using a two-tailed Mann–Whitney U test. Top, **P = 0.0064 (CNOT2), *P = 0.0414 (CCL4), **P = 0.009 (IL18RAP), *P = 0.0361 (KLRG1), *P = 0.0163 (KLRC1), *P = 0.0371 (LYN), **P = 0.0095 (SAMD3), *P = 0.0395 (SYNE1). Bottom, *P = 0.0126 (CCL5), *P = 0.0354 (FGFBP2), *P = 0.0373 (ITGA4), *P = 0.018 (ITGAM), *P = 0.031 (KLRB1), *P = 0.032 (KLRC1). c, log2FC and adjusted P values of a DEG analysis (based on a two-tailed Wald test with Benjamini–Hochberg P-value adjustment) between exTreg cells and Treg cells for the 13 CAD-relevant exTreg genes from b.